Business - Briefly   

Ranbaxy recommends final dividend

NEW DELHI: : Ranbaxy Laboratories has recommended a final dividend of Rs. 12 per share. For the quarter ended March 31, 2005, the consolidated sales were Rs. 1,138 crores against Rs. 1,308 crores. The profit after tax stood at Rs. 70.80 crores against Rs. 190.60 crores. The directors have approved a stock split of the existing equity shares of Rs. 10 each into the face value of Rs. 5 per share.

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts: Classifieds | Employment | Obituary | Updates: Breaking News |

Stories in this Section

RBI asks banks to focus on deposit mobilisation
Ashok Leyland sales cross $1 b
New mode of SSI financing
Bharti Tele net zooms
Eveready Ind turns around
Novell enters new arena
Now, nuclear fusion in a lab
TRAI order on rate cut struck down
Oscar of business world
Varun Shipping to go in for SDR
Wockhardt's plant in Himachal Pradesh
GDP estimation on new base
Rupee recovers
Bank stocks suffer sharp setback
Overseas investment ceiling raised
Loan limit to farmers up
M&A guidelines on private banks shortly
`Lending rates will not be affected'
Exchange rates
Bullion rates
Ranbaxy recommends final dividend
40 p.c. dividend from Raymond
BHEL net profit up
Glaxosmithkline consumer PAT up
Subex Systems pays 20 p.c. final
EID Parry recommends 125 p.c.

Copyright © 2005, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu